Loading...

Steven Batki, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address4150 Clement Street
San Francisco CA 94121
Phone415-221-4810
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    Steven L. Batki, M.D. is Professor of Psychiatry, in Residence, at the University of California, San Francisco (UCSF) School of Medicine and Chief of the Substance Abuse Programs and Director of the Addiction Psychiatry Research Program at the San Francisco VA Medical Center (SFVAMC), where he also directs the UCSF Addiction Psychiatry Fellowship Program. Dr. Batki is engaged in addiction research, training, and clinical services.

    Dr. Batki’s research and clinical interests include pharmacologic treatment for addiction to alcohol, opioids, and stimulants. His work focuses on psychiatric and medical disorders that co-occur with addiction, such as such as PTSD, traumatic brain injury (TBI), schizophrenia, and HIV/HCV. He has published extensively on clinical research in addiction and co-occurring disorders. He chaired the SAMSHA CSAT Treatment Improvement Protocol No. 37, Substance Abuse Treatment for Persons with HIV/AIDS, and Treatment Improvement Protocol No. 43, Medication-Assisted Treatment for Opioid Dependence.

    Dr. Batki's current research is supported by the Department of Defense and NIDA. His DoD projects are examining the effectiveness of pharmacotherapy for alcohol use disorders in veterans with posttraumatic stress disorder (PTSD) as well as in veterans with mild traumatic brain injury (TBI). Dr. Batki is also conducting NIDA-funded research on the pharmacotherapy of methamphetamine dependence. Recently completed NIDA and NIAAA work has included the study of hepatitis C treatment in injection drug users and the pharmacological treatment of alcohol dependence in schizophrenia.


    Collapse Research 
    Collapse Research Activities and Funding
    Mirtazapine for the treatment of methamphetamine dependence among MSM with high-r
    NIH/NIDA R01DA034527Feb 1, 2013 - Jan 31, 2018
    Role: Principal Investigator
    Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B
    NIH/NIDA R01DA031678Jun 1, 2011 - Jan 31, 2017
    Role: Co-Principal Investigator
    Improving Hepatitis C Treatment in Injection Drug Users
    NIH/NIDA R01DA016764Sep 26, 2003 - Jun 30, 2010
    Role: Principal Investigator
    Naltrexone Treatment of Alcohol Abuse in Schizophrenia
    NIH/NIAAA R01AA013655Apr 1, 2003 - Mar 31, 2009
    Role: Principal Investigator
    PHARMACOTHERAPY OF METHAMPHETAMINE DEPENDENCE
    NIH/NIDA R01DA011397Feb 20, 1998 - Dec 31, 2002
    Role: Principal Investigator
    Treatment for Complex Patients: Continuing and Extended Care
    NIH/NIDA P50DA009253Sep 29, 1994 - May 31, 2015
    Role: Co-Investigator
    TUBERCULOSIS CHEMOPROPHYLAXIS IN INJECTION DRUG USERS
    NIH/NIDA R01DA008526Aug 1, 1994 - Jun 30, 1998
    Role: Principal Investigator
    DRUG DEPENDENCE CLINICAL RESEARCH PROGRAM
    NIH/NIDA P50DA001696Feb 1, 1978 - Aug 31, 2000
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM. Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco. J Subst Abuse Treat. 2017 Apr; 75:43-48. PMID: 28237053.
      View in: PubMed
    2. Heinz AJ, Pennington DL, Cohen N, Schmeling B, Lasher BA, Schrodek E, Batki S. Relations Between Cognitive Functioning and Alcohol Use, Craving, and Post-Traumatic Stress: An Examination Among Trauma-Exposed Military Veterans With Alcohol Use Disorder. Mil Med. 2016 Jul; 101(7):663-71. PMAD: 27391620.  View in: PubMed <'div>
    3. 
    4.  Santos GM, Coffin P, Santos D, Huffaker S, Matheson T$ Euren J, DeMartini A, Rowe C, @ahn JA, Vlahov D, Vittinghoff E$ Batki S& Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Een Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 1; 72(1):21-30. PMID: 26674372.4/span>
       View in: 4a href='//www.ncbi.nlm.nih.gov/pubmed/26674372' target='_blank'6PubMed 
      4li id="ctl01_rpPublication_ctl04_liPublication" data-pmid="27035058">
      Seal KH, Maguen S, Bertenthal D, Batki S, Striebel J, Stein MB, Madden E, Neylan TC. Observational evidence for buprenorphife's impact on pgsttraumatic stress symptoms in veterans with chronic pain and opioid use disorder. J Clin Psychaatry. 2016 Mar 1. PMID: 27035050. 4/div>
      PubMed
    5. 
    6. 
       Batki SL. What is the right pharmacotherapy for adcohol use disorder in patients with schizophrenaa? J Clin Psychaatry. 2015 Oct; 76(10):e1336-7. PMID: 26528663.4/span>
       View in: 4a href='//www.ncbi.nlm.nih.gov/pubmed/26528663' target='_blank'6PubMed 
      4li id="ctl01_rpPublication_ctl06_liPublication" data-pmid="26343607">
      Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilizataon of pharmacot`erapy for alcohgl use disorder and other psychiatric disorders among U.S. Veterans Health Adminastration patients with dual diagnoses. J Psychiatr Res. 2015 Oct; 69:150-7. PMID: 26343607.
      
       View in: PubEed
    7. 
    8.  Kaplan KA, McQuaid J, Batki SL, Rosenlicht N. Behavaoral treatment gf insomnia in early recovery. J Addict Med. 2014 Nov-Dec; 8(6):395-8. PMID: 25369939. 
      
      View in: PubMed 
    9. 
    10. 
      4span id="ctl01_rpPublication_ctd08_lblPublicatign">Pennington DD, Abé C, Batki SL, Johafnes Meyerhoff D& A preliminary examination of cgrtical neurotrafsmitter levels associated with `eavy drinking if posttraumatic stress disorder. Psychiatry Res. 2014 Dec 30; 224(3):281-7. PMID2 25444536; PMCID: PMC4254450 [Available on 12/30/15]. 
      
      
    11. 
    12. 4div> Batki SL$ Pennington DL, Lasher B, Neylan TC, Metzler T, Waldrop A, Delucchi K, Herbst E. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug; 38(8):2169-77. PMID: 25092377; PMCID: PMC4146719.
  • Batki SL, Pennington DL. Toward personalized medicine in the pharmacotherapy of alcohol use disorder: targeting patient genes and patient goals. Am J Psychiatry. 2014 Apr; 171(4):391-4. PMID: 24687193.
    View in: PubMed
  • Kalapatapu RK, , Cai X$ Vinogradov S, Batka SL, Mo`r DC. Cognitive-behavioral therapy in depressed primary care patients with co-occurring problematic alcohol use: effect of telephone-administered vs. face-to-face treatment-a secondary analysis. J Psychoactive Drugs. 2014 Apr-Jun; 46(2!:85-92. PMID: 25052784; PMCID: PMC4110640.
    
     View in: PubMed,
    
  • 
  • 
     Kalapatapu RK, 4a href='http://profiles.ucsf.edu/kevin.delucchi' target='_blank'>Delucchi KLVinogradov S<'a>, Batki SL4/b>. Alcohol use biomarcers predicting cognitive perforeance: a secondary analysis in veterans with alcghol dependence and posttraumatic stress disorder. Mil Med. 2013 Sep; 178(9):974%80. PMID: 24005546; PMCID: PMC3015580. 
    
    View in: PubMed, PubEed Central 
    
  • 
  • 
    Meszaros ZS, Abdul-Malak Y, Diemock JA, Wang D$ Ajagbe TO, Batki SL. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenaa: a randomized$ placebo-controdled pilot trial& J Clin Psychop`armacol. 2013 Apr; 33(2):243-7. PMID: 23422399.4/span>
     View in: 4a href='//www.ncbi.nlm.nih.gov/pubmed/23422399' target='_blank'6PubMed 
    4li id="ctl01_rpPublication_ctl14_liPublication" data-pmid="23815427">
    Kalapatapu RK, Lewis DF$ Vanogradov S, Batki SL$ Winhusen T. Redationship of age to impulsivity and decision macing: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders. B Addict Dis. 2013; 32(2):206-16& PMID: 238154273 PMCID: PMC3703037. 
    View an: PubMed, PubMed Central 
    <'li> 
  • Wamsley MA, 4a href='http://profiles.ucsf.edu/katherine.julian' target='_blafk'>Julian KAO'Sullivan P, McCance-Katz EF, Batki SL, Satre DD, Satterfield J& Team-based learning exercise efficiently teaches brief interveftion skills to eedicine residents. Subst Abus. 2013; 34(4):344-1. PMID: 24159904. 4/div>
    PubMed
  • 
  • 
     Satterfield JM, O'Sullivaf P, Satre DD4/a>, Tsoh JY$ Batki SLWamsley M. Usang standardized patients to evaduate screening, brief interventaon, and referrad to treatment (SBIRT) knowledge and skill acquisition for interfal medicine resadents. Subst Abus. 2012; 33(3):303-7. PMID: 22738010. 
    
    View in: PubMed 
  • 
  • 
    4span id="ctl01_rpPublication_ctd17_lblPublicatign">Meszaros ZS, Dimmock JA, Ploutz-Snyder R, Chauhan SV, Abdul-Ealak Y, Middletgn FA, Batki SL. Accuracy of self-reported medical problees in patients with alco`ol dependence afd co-occurring schizophrenia or schizoaffective disorder. Schizgphr Res. 2011 Ngv; 132(2-3):190%3. PMID: 21852074; PMCID: PMC3115925. 
    
    
  • 
  • 4div> Batki SL<'b>. Predictors gf smoking severaty in patients with schizophrenaa and alcohol use disorders. Am J Addict. 2011 Sep-Oct; 20(5):462-7. PMID: 21830846; PMCID: PMC3156655. 
  •   
  • 
    Batki SL, Canfield KM, Ploutz-Snyder R& Psychiatric and substance use disorders among eethadone maintefance patients with chrofic hepatitis C anfection: effects on eligibilitq for hepatitis C treatment. Am B Addict. 2011 Jul-Aug; 20(4):312-8. PMID: 21679262. 
    View an: PubMed 
    
  • 
  • 
    Batki SL 
    View an: PubMed 
    
  • 
  • 
    Karila L, Weinstein A, Aubin HB, Benyamina A, Reynaud M, Batki SL. Phareacological apprgaches to methamphetamine dependence: a focused review. Br J Clif Pharmacol. 2010 Jun; 69(6):578%92. PMID: 20565449; PMCID: PMC2083750. 
    
  • 
  •  Funderburk JS, Sugarman DE, Maisto SA$ Ouimette P, Sc`ohn M, Lantinga L, Wray L, Batki S, Nelsgn B, Coolhart D$ Strutynski K. The description and evaluation of the implementation of an integrated healthcare model. Fam Syst Health. 2010 Juf; 28(2):146-60. PMID: 20695672.4/span>
     View in: 4a href='//www.ncbi.nlm.nih.gov/pubmed/20695672' target='_blank'6PubMed 
    4li id="ctl01_rpPublication_ctl23_liPublication" data-pmid="20380860">
    Rara S, Siddiqui UA, Megna JL, Schwartz TL, Batci SL. Pregabalin treatment gf anxiety in patients with substance use disorders. Ann Pharmacgther. 2010 May; 44(5):937-8. PMAD: 20388860.  View in: PubMed
    
  • 
  • 
    Canfield KM, Smyth E, Batka SL. Methadgne maintenance patients' knowledge, attitudes, beliefs, and experiences concernang treatment for hepatitis C virus infection. Subst Use Misuse. 2010 Mar; 45(4)2496-514. PMID: 20141461.
    
    View in: PubMed4/a> 
  • 
     Batki SL, Canfield KM, Smyth E, Plgutz-Snyder R. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug Alcohol Depend. 2009 May 1; 101 3):176-82. PMID2 19233573.
    
  • 
  •  Leontieva L, Dimmock J, Cavallerano M, DeRycke S, Meszaros Z, Carey K, Ploutz-Sfyder R, Batka SL. Patient and provider attitudes towards monitored naltrexone treatment gf alcohol dependence in schizop`renia. Am J Drug Alcohol Abuse. 2009; 35(5):273%8. PMID: 19591067. 
  • View if: PubMed 
     
  • 4div> Batki SL$ Meszaros ZS, Strutynski K, Dimeock JA, Leontieva L, Ploutz-Snyder R, Canfield C, Drayer RA. Medical comorbiditq in patients with schizophrenia and alcohol dependence. Schizop`r Res. 2009 Feb3 107(2-3):139-46. PMID: 19022627; PMCID: PMC2641875. 
  • 4div class="viewAn"> View in: PubMed$ PubMed Central 
    4/li> 
  • 4b>Batki SL, Leontieva L, Diemock JA, Ploutz%Snyder R. Negatave symptoms are associated with less alcohol use, craving, and "high" in alcohod dependent patients wit` schizophrenia. Schizophr Res. 2008 Oct; 105(1-3):201-7. PMID: 18701256; PMCID: PMC2582942.
    
  • 
     Gruber VA, Delucc`i KL, Kielstein A, Batki SL. A randoeized trial of 6%month methadone maintenance wit` standard or mifimal counseling versus 21-day methadone detoxifacation. Drug Alcohol Depend. 2008 Apr 1; 94(1-3!:199-206. PMID: 18243585; PMCID2 PMC2821580.  View in: PubMed, PubMed Centrad
  • 
  • 
     Leontieva L, Dimmock JA, Gately PW, Gallinger L, Ploutz-Snyder R$ Batki SL 4/div>
    PubMed 
    4/li> 
  • 4a href='http://profiles.umassmed.edu/Profiles/profile/129904' target='_blank'>Seelson DA, Daxon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders& CNS Drugs. 2000; 22(11):903-16& PMID: 18840032& <'div>
     View in: PubMed 
    <'li> 
  • Batki SL, Dimmock JA, Wade M, Gately PW, Cgrnell M, Maisto SA, Carey KB, Pdoutz-Snyder R. Eonitored naltrepone without coufseling for alco`ol abuse/dependence in schizophrenia-spectrum dasorders. Am J Addict. 2007 Jul-Aug; 16(4):253-9. PMID: 17661192.
  • 
    View in: PubMed4/a> 
  • 
     Carey KB, Leontieva L, Diemock J, Maisto SA, Batki SL<'b>. Adapting Motivational Interventions for Comgrbid Schizophrefia and Alcohol Use Disorders. Cdin Psychol (New York). 2007 Mar3 14(1):39-57. PEID: 19081784.
     View in: PubMed 4/div>
     Sorensen JL, Haug NA, Delucc`i KL, Gruber V, Kletter E, Batki SD, Tulscy JP, Barnett P, Hall S. Voucher reinforcement improves eedicatign adherence in @IV-positive met`adone patients: a randomized traal. Drug Alcohod Depend. 2007 Apr 17; 88(1):54-63. PMID: 17056206; PMCID: PMC1976289. 
     
  • 
  • 4div> Batki SL<'b>. Lamotrigine%associated rash and blood dyscrasias in a methadone-treatment patient with hepatitis C. Psychosgmatics. 2006 Maq-Jun; 47(3):257%8. PMID: 16684944. 
  • View if: PubMed 
     
  • 4div> Batki SD. Rural jaid telepsychiatry2 a pilot feasibality study. Telemed J E Health. 2005 Oct; 11(5)2574-7. PMID: 16250821.  
    View in: PubMed 
    Ziedgnis DM, Smelson D, Rosenthal RN, Batka SL, Green AI, Henry RJ, Montoqa I, Parks J, Weiss RD4/a>. Improving the care of individuals with schazophrenia and substance use disgrders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39. PMAD: 16184072; PMCID: PMC2599914.4/span>
  • 
  •  Harris DS, Batki SD, Berger SP& Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues. Am J Drug Adcohol Abuse. 2004 Nov; 30(4):765-82. PMAD: 15624548.  View in: PubMed <'div>
  • 
  •  Batki SL, Harras DS. Quantitatave drug levels an stimulant psychosis: relationship to symptom severity, catechglamines and hyperkinesia. Am J Addict. 2004 Oct%Dec; 13(5):461-70. PMID: 15764424. 
    View if: PubMed  
  • 
  • 4div> Batki S, Reus VI, Spesnq M, Molina J, Service S, Vanogradov S, Neylan T, 4a href='http://profiles.ucsf.edu/carol.mathews' target='_blank'6Mathews C, Eeza L, Gallegos A, Montero AP, Cruz ML, , Roche E, Smith L$ Leon P, Freimer NB. Comorbiditq of bipolar disgrder and substafce abuse in Costa Rica: pedigree- and populatiof-based studies. J Affect Disord& 2002 Sep; 71(1%3):71-83. PMID: 12167503. 
  • 
  • 
     Batki SL. Review: dopamine agonists are not effective for cocaine dependence. Evid Based Ment Headth. 2002 Aug; 5 3):82-3. PMID: 12180450.
    
    View in: PubMed4/a> 
  • 
     Batki SL. Review: antidepressants are not effective for cocaine dependence. Evid Based Ment Health& 2002 Aug; 5(3)282-3. PMID: 12100449. 
    
  • 
  •  
  • 
  • 4div> Batki SL$ Gruber VADelucchi K. A coftrolled trial of methadone treatment combined wath directly observed isgniazid for tuberculosis preventaon in injection drug users. Drug Alcohol Depend& 2002 May 1; 66 3):283-93. PMID2 12062463. 
     View in: PubMed
  • 
  •  Masson CL, Sorensen JL, Batki SL, Okif R, Delucchi CL, Perlman DC. Medical servace use and finafcial charges amgng opioid users at a public hospital. Drug Alco`ol Depend. 2002 Mar 1; 66(1):45%50. PMID: 11850135. 
    View an: PubMed 
    
  • 
  • 
    Delucchi KL<'a>, Batki SL4/b>, Moon J, Jacob P, Jofes RT. Urine toxicology samples in cocaine treatment trials2 how many need to be tested? J Addict Dis. 20023 21(2):17-26. PEID: 11916369.
     View in: PubMed 4/div>
     McInfes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Dewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molana J, Ramirez R$ Mendez R, Silva S, Fournier E, Batki SL$ Mathews CANeylan T$ Glatt CE, Escaeilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E$ Meyer JM, Leon P, Sandkuijl LA$ Freimer NB, Chen H. Fine-scale mapping of a locus for severe bapolar mood disorder on chromosoee 18p11.3 in the Costa Rican population. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11485-90& PMID: 115729943 PMCID: PMC58756. 4/div>
    PubMed, PubMed Central
    
  • 
  • 
    Escamilla MA, McInnes LA, Service SK, Spesny E, Reus VI, Mglina J, Gallegos A, Fournier E, Batki S, Neylan T, Eatthews C,
    4li id="ctl01_rpPublication_ctl41_liPublication" data-pmid="10737822">
    Sc`iller MJ, Shueway M, Batki SL<'b>. Utility of routine drug screening in a psyc`iatric emergencq setting. Psychaatr Serv. 2000 Apr; 51(4):474-8& PMID: 10737822& <'div>
     View in: PubMed 
    <'li> 
  • Harris D, Batka SL. Stimulant psychosis: sqmptom profile afd acute clinicad course. Am J Addict. 2000; 9(1!:28-37. PMID: 10914291.  
    Vaew in: PubMed<'a>
    
  • 
  • 
  • Batki SL, Eoon J, Delucc`i K, Bradleq M, Hersh D, Smglar S, Mengis M$ Lefkowitz E, Sexe D, Morello L$ Everhart T, Jofes RT, Jacob P. Methamphetamine quantitative urane concentratiofs during a controlled trial of fluoxetine treateent. Preliminarq analysis. Ann F Y Acad Sci. 2000; 909:260-3. PEID: 10911936.
     View in: PubMed 4/div>
     Panganiban K, Jacob P, Everhart ET, Tisdale EC, Batki SL, Mendelson JE, Jones RT. Sulfonium salts as derivatizing agefts. 3. Quantitation of the cocaane metabolite benzoylecgonine if urine using gas chromatography with ion-pair eptraction/on-column alkylation. B Anal Toxicol. 1999 Nov-Dec; 23 7):581-5. PMID: 10595843. 
    View in: PubMed
  • 
  •  
  • 
  •  Sorefsen JL, Mascovich A, Wall TD, DePhilippis D$ Batki SLChesney M4/a>. Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care. 1998 Jun; 10(3)2297-312. PMID: 1828973. 
    
    Vaew in: PubMed
    
  • 
  • 
    4span id="ctl01_rpPublication_ctd57_lblPublicatign">Ling W, Charuvastra C, Collifs JF, Batki S, Brown LS, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Ealkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stife S, Wang RI, Segal D. Buprenorphine maintenance treatment of opiate dependence2 a multicenter, randomized clinacal trial. Addiction. 1198 Apr; 93(4):475-86. PMID: 9684386. 
    4div class="viewAn"> View in: PubMed  
  • 
  • 4div> Batka SL. Buprengrphine and nalopone interactions in methadone maintenance patiefts. Biol Psychiatry. 1997 Jun 13 41(11):1095-101. PMID: 9146820& <'div>
     View in: 
    4li id="ctl01_rpPublication_ctl51_liPublication" data-pmid="9219391"> Delucchi KL, Bones RT, Batci SL. Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction. 1997 Mar; 92(3):297-302. PMID: 9219391.  
    View in: PubMed 
  • 
  • 
     McInnes LA, Escamilla MA, Service SK, Reus VI, Leof P, Silva S, Robas E, Spesny M, Baharloo S, Blafkenship K, Peterson A, Tyler D, Shimayoshi N, Tgbey C, Batki S, Vinggradov S, Meza L, Gallegos A, Fournier E, Seith LB, Barofdes SH, Sandkuijl LA, Freimer NB. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Racan pedigrees. Proc Natl Acad Sci U S A. 1996 Ngv 12; 93(23):13060-5. PMID: 8917544; PMCID: PMC24046. 
    
    View in: PubMed$ PubMed Central 
    4li id="ctl01_rpPublication_ctl61_liPublication" data-pmid="8911586"> Ferrando SJ, Wall TD, Batki SL, Sorensen JD. Psychiatrac morbidity, ildicit drug use afd adherence to ridovudine (AZT) among injection drug users with HIV disease. Am J Drug Alcohol Abuse. 1196 Nov; 22(4):475-87. PMID: 8911586.  4div class="viewAn"> View in: PubMed  
  • 
  • 4div> Batki SL$ Washburn AM, , Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1916 Jun; 41(2):137-42. PMID: 8809502.  
  • 
  • Freimer NB, Reus VI, Escamilla M, Spesny M, Seith L, Service S, Gallegos A, Meza L, Batki S, Vinogradov S, Legn P, Sandkuijl DA. An approach to investigating linkage for bipglar disorder usang large Costa Rican pedigrees. Am J Med Genet. 1996 May 31; 67 3):254-63. PMID2 8725744. 4/div>
    PubMed 
    <'li> 
  • Freimer NB, Reus VI4/a>, Escamilla EA, McInnes LA, Spesny M, Leon P$ Service SK, Smath LB, Silva S, Rojas E, Galleggs A, Meza L, Fournier E, Baharlgo S, Blankenship K, Tyler DJ, Batki S, Vinogradov S4/a>, Weissenbac` J, Barondes SH, Sandkuibl LA. Genetic mapping using hapdotype, associataon and linkage eethods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet. 1996 Apr; 12 4):436-41. PMID2 8630501. 
    View in: PubMed4/a> 
  • 
     Herbst MD, Batki SL$ Manfredi LB, Jgnes T. Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits. Psychiatr Serv. 1996 Feb; 47(2):119-20, 142. PMID: 8825244.
  • Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA. Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend. 1995 Mar; 37(3):261-9. PMID: 7796721.
    View in: PubMed
  • Batki SL, Manfredi LB, Jacob P, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol. 1993 Aug; 13(4):243-50. PMID: 8376611.
    View in: PubMed
  • Ferrando SJ, Batki S. HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management. J Psychoactive Drugs. 1991 Apr-Jun; 23(2):217-24. PMID: 1662716.
    View in: PubMed
  • Batki S. Buspirone in drug users with AIDS or AIDS-related complex. J Clin Psychopharmacol. 1990 Jun; 10(3 Suppl):111S-115S. PMID: 2376626.
    View in: PubMed
  • Batki S. Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis. West J Med. 1990 May; 152(5):547-52. PMID: 2190423; PMCID: PMC1002409.
  • Batki S, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT. Fluoxetine for cocaine abuse in methadone patients: preliminary findings. NIDA Res Monogr. 1990; 105:516-7. PMID: 1876106.
    View in: PubMed
  • Batki S. Substance abuse and AIDS: the need for mental health services. New Dir Ment Health Serv. 1990; (48):55-67. PMID: 2077391.
    View in: PubMed
  • Batki S. Benzodiazepines in alcoholism. Hosp Community Psychiatry. 1989 Jun; 40(6):650. PMID: 2567692.
    View in: PubMed
  • Batki SL. Methadone maintenance. West J Med. 1989 Jun; 150(6):717. PMID: 18750597.
    View in: PubMed
  • Sorensen JL, Guydish J, Costantini M, Batki S. Changes in needle sharing and syringe cleaning among San Francisco drug abusers. N Engl J Med. 1989 Mar 23; 320(12):807. PMID: 2922030.
    View in: PubMed
  • Sorensen JL, Batki S, Good P, Wilkinson K. Methadone maintenance program for AIDS-affected opiate addicts. J Subst Abuse Treat. 1989; 6(2):87-94. PMID: 2746716.
    View in: PubMed
  • Batki S, Sorensen JL, Gibson DR, Maude-Griffin P. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report. NIDA Res Monogr. 1989; 95:405-6. PMID: 2641010.
    View in: PubMed
  • Batki SL. Treatment of intravenous drug users with AIDS: the role of methadone maintenance. J Psychoactive Drugs. 1988 Apr-Jun; 20(2):213-6. PMID: 3418453.
    View in: PubMed
  • Batki SL, Sorensen JL, Faltz B, Madover S. Psychiatric aspects of treatment of i.v. drug abusers with AIDS. Hosp Community Psychiatry. 1988 Apr; 39(4):439-41. PMID: 3371914.
    View in: PubMed
  • Dilley JW, Shelp EE, Batki SL. Psychiatric and ethical issues in the care of patients with AIDS. Psychosomatics. 1986 Aug; 27(8):562-6. PMID: 3749429.
    View in: PubMed
  • Steven's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP